CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 306 enrolled
Drug / intervention
Rise - Treatment Educationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03331978
NCT03331978N/ACompleted
CompareCT.gov

A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans

RAND·interventional·Posted Nov 6, 2017·Updated Jan 18, 2023

In Brief

A clinical study evaluating Rise - Treatment Education for HIV/AIDS. Completed, enrolled 306 participants across 1 site.

Detailed Summary

Project Rise is a randomized controlled trial (RCT) of an innovative, culturally congruent treatment education (TE) intervention for African Americans with HIV that targets cultural and social issues contributing to health disparities.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV/AIDS
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 6, 2017
Enrollment StartJan 23, 2018
Primary CompletionNov 7, 2021
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 8.7 years ago

Interventions

Rise - Treatment Educationbehavioral

Rise consists of a one-month intensive intervention (with three core 60-minute counseling sessions at weeks 1, 2, and 4) followed by two booster sessions (at weeks 12 and 20). If participants show nonadherence during booster sessions, they are offered up to four additional booster sessions (i.e., extra booster sessions if \<85% of prescribed doses were taken in the past month). Thus, participants receive three core sessions in the first month, followed by 2-6 booster sessions over the next four months.